Oncology

Myelofibrosis

Conference Reporter® in Myelofibrosis to Cover Key Topics Being Presented at the 2026 ASCO Annual Meeting

conference reporter by Rami S. Komrokji, MD; Raajit K. Rampal, MD, PhD

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Myelofibrosis presented at the 2026 ASCO Annual Meeting.

VIEW THE TOPICS:

Investigational Agents and Recent Advances in Therapy in Myelofibrosis
MOA of JAK Inhibitors and Novel MOAs in Myelofibrosis
Progressive Disease in Myelofibrosis
Risk Assessment and Prognosis in Myelofibrosis

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.

2026 ASCO Annual Meeting

May 29 – June 2, 2026

McCormick Place

Chicago, IL

Registration Link

Profile

Rami S. Komrokji, MD

Vice Chair, Department of Malignant Hematology
Senior Member, Malignant Hematology and Experimental Therapeutics Program
Moffitt Cancer Center
Professor of Medicine and Oncologic Sciences
University of South Florida Health Morsani College of Medicine
Tampa, FL

Profile

Raajit K. Rampal, MD, PhD

Associate Member
Director, Myeloproliferative Neoplasms Program
Director, Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, NY